Corrigendum: The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

Frontiers in Virology

Virology

Gerry A. F. Nicolaes¹  Kanin Wichapong¹  Angela Phillips²  Michael M. Desai²  Wouter Koudstaal³  Clarissa M. Koch³  Jaco M. Klap³  Jacopo Frallicciardi³  Anna L. Beukenhorst⁴  Jaap Goudsmit⁵  Galit Alter⁶ 

[1] Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands;Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, United States;Leyden Laboratories B.V., Amsterdam, Netherlands;Leyden Laboratories B.V., Amsterdam, Netherlands;Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, United States;Leyden Laboratories B.V., Amsterdam, Netherlands;Departments of Epidemiology, Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, United States;Leyden Laboratories B.V., Amsterdam, Netherlands;Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard, Cambridge, MA, United States;

关键词: broadly neutralizing antibodies;    influenza virus;    pan-influenza protection;    CR9114;    correlate of protection;    antiviral therapies;    immunization;    vaccination;   

DOI  :  10.3389/fviro.2023.1130102

 received in 2022-12-22, accepted in 2023-01-17,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Beukenhorst, Frallicciardi, Koch, Klap, Phillips, Desai, Wichapong, Nicolaes, Koudstaal, Alter and Goudsmit